Michel Baijot
Direktor/Vorstandsmitglied bei DMS IMAGING
Ursprung des Netzwerks ersten Grades von Michel Baijot
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019.
8
| Private Company | Packaged Software | 8 |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium.
6
| Subsidiary | Biotechnology | 6 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.
6
| Subsidiary | Medical Specialties | 6 |
OncoRadiomics SA
 OncoRadiomics SA Investment Trusts/Mutual FundsMiscellaneous OncoRadiomics SA functions as a foundation or endowment. Its products include radiomix, distrim and virtual patient auatar. The company was founded by Ralph Leijenaar, Sean Walsh and Tulcinsky Paul on September 19, 2016 and is headquartered in Liège, Belgium.
2
| Holding Company | Investment Trusts/Mutual Funds | 2 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Serum Institute of India Pvt Ltd.
 Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Serum Institute of India Pvt Ltd. engages in the production and exportation of anti-cancer products and viral vaccines. Its products include bacterial vaccines, recombinant and combination vaccines, viral vaccines, influenza vaccines. uro-oncology, and polysaccharide conjugate vaccine. The company was founded by Cyrus S. Poonawalla in 1966 and is headquartered in Pune, India.
1
| Subsidiary | Biotechnology | 1 |
White Fund SA
 White Fund SA Investment ManagersFinance White Fund SA invests in companies located in Belgium and possibly neighbouring regions. It targets companies operating in the medical device sector. It provides financing for early stage with an investment size ranging between €2 million and €5 million per project. Exits are targeted after 5-7 years.
1
| Venture Capital Fund | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michel Baijot
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Ghent University | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| Université Catholique de Louvain | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BIOCARTIS GROUP NV | Medical Specialties | Chairman Chief Executive Officer | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member | |
BARC SCS
 BARC SCS Miscellaneous Commercial ServicesCommercial Services BARC NV provides central laboratory services. It specializes in testing wide range of fields including virology, microbiology, clinical pathology, and genetics. The firm offers biobanking, cerba specimen, custom test development, data management, investigator support, project management, and logistics. The company is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
| Université Libre de Bruxelles | College/University | Graduate Degree Doctorate Degree | |
| ATON | Pharmaceuticals: Major | Chairman Director/Board Member | |
| THERADIAG | Medical Specialties | Chief Executive Officer Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Chief Executive Officer | |
| University of Liege | College/University | Undergraduate Degree Undergraduate Degree | |
| Apelem SASU | Chairman Chief Executive Officer | ||
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
SCI JPS Immobilier
 SCI JPS Immobilier Real Estate DevelopmentFinance SCI JPS Immobilier engages in the rental of land and other real estate properties. The private company is based in Sainte-Thorette, France. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| ICHEC | College/University | Undergraduate Degree Graduate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director of Finance/CFO | |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| DIAGNOSTIC MEDICAL SYSTEMS | Medical Specialties | Chief Executive Officer Chairman | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| SUNCANI HVAR D.D. | Hotels/Resorts/Cruise lines | Director/Board Member | |
| FPB Advisory & Services | Director/Board Member | ||
| Duke University School of Medicine | College/University | Doctorate Degree | |
Q-Biologicals NV
 Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
| Univac NV | Director/Board Member | ||
| ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member | |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Medical/Nursing Services | Director/Board Member | |
Sailsense Analytics SA
 Sailsense Analytics SA Recreational ProductsConsumer Durables Sailsense Analytics SA manufactures boats. The private company is based in Brussels, Belgium and has subsidiaries in France. The Belgian company was founded in 2017 by Nicolas de Laet and Yannick Vereerstraeten, with Nicolas de Laet serving as CEO since 2017. | Recreational Products | Director/Board Member | |
| Tree Digital Factory SAS | Director/Board Member | ||
| 3t PT Investimentos SGPS SA | Director/Board Member | ||
| Eurobiotech SA | Director/Board Member | ||
4 for Cells SRL
 4 for Cells SRL Data Processing ServicesTechnology Services 4 for Cells SPRL provides business outsourcing services. The private company is based in Hastière, Belgium. The Belgian company was founded in 2011. François Lesage has been the CEO of the company since 2011. | Data Processing Services | Director/Board Member | |
DNAlytics SA
 DNAlytics SA Data Processing ServicesTechnology Services DNAlytics SA engages in the development of data-driven precision medicine solutions. The firm provides consultancy services; and academic medical, biological, and clinical research laboratories for the pharmaceutical, biotechnology and In-Vitro Diagnostic companies. It also offers software programs unde rthe REED, LiblineaR, jForest, and BLISS brands. The company was founded by Pierre Dupont and Thibault Helleputte in 2012 and is headquartered in Louvain-la-Neuve, Belgium. | Data Processing Services | Director/Board Member | |
| YD Advisory & Services | Director/Board Member | ||
Nabul Construmat SL
 Nabul Construmat SL Engineering & ConstructionIndustrial Services Nabul Construmat SL is a Spanish company that operates as masonry contractors. The private company is based in Barcelona, Spain. | Engineering & Construction | Director/Board Member | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| CPI FIM SA | Real Estate Investment Trusts | Director of Finance/CFO | |
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member | |
20Med Therapeutics BV
 20Med Therapeutics BV BiotechnologyHealth Technology 20Med Therapeutics BV operates as a biomedical company. It focuses on the development of biodegradable materials for biomedical applications and multifunctional nanosystems for controlled drug and gene delivery. The company was founded by Johan F. J. Engbersen in 2011 and is headquartered in Enschede, the Netherlands. | Biotechnology | Director/Board Member | |
BGP Investment SARL
 BGP Investment SARL Financial ConglomeratesFinance BGP Investment SARL operates as a real estate company. It offers residential, retail, and light industrial portfolio. The company was founded in 2005 and is headquartered in the Luxembourg. | Financial Conglomerates | Director of Finance/CFO | |
| Thémis SA | Director/Board Member | ||
| Fyp SA | Director/Board Member |
Statistik
International
| Belgien | 27 |
| Frankreich | 10 |
| Schweiz | 3 |
| Luxemburg | 3 |
| Niederlande | 3 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 4 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 214 |
| Corporate Officer/Principal | 71 |
| Chairman | 39 |
| Chief Executive Officer | 37 |
| Chief Tech/Sci/R&D Officer | 34 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| François Fontaine | 34 |
| Jean-Paul Prieels | 32 |
| Rudi Mariën | 31 |
| Yves Jean Marie Désiront | 25 |
| Harry Welten | 22 |
| Frank Morich | 21 |
| Hilde Windels | 18 |
| James Tursi | 17 |
| Jean-Paul Ansel | 17 |
| Marian Nakada | 16 |
| Philippe Degeer | 15 |
| Rudi de Winter | 15 |
| Gerd Zettlmeissl | 11 |
| Duane A. Morris | 11 |
| Filip Goossens | 11 |
- Börse
- Insiders
- Michel Baijot
- Unternehmensverbindungen
